proteinuria

Open Access
Efficacy and Safety of Anti-angiogenic Agents for Cancer Patients With Proteinuria or a History of Proteinuria: A Systematic Review
TAIGO KATO, SHIMON KURASAWA, KENTARO TAKEZAWA, YUTAKA FUJIWARA, YOSHINARI YASUDA and YUICHI ANDO

Anticancer Research March 2024, 44 (3) 889-894; DOI: https://doi.org/10.21873/anticanres.16882
Open Access
Relationship Between Safety and Cumulative Bevacizumab Dose in Patients With Metastatic Colorectal Cancer Who Received Long-term Bevacizumab Treatment
SATOSHI FUKUDA, YUSUKE NIISATO, MIKI TSUJI, SOMA FUKUDA, YUYA HAGIWARA, TSUBASA ONODA, HIROSUMI SUZUKI, YOSHITAKA TANGE, TAKESHI YAMADA, YOSHIYUKI YAMAMOTO and TOSHIKAZU MORIWAKI

Anticancer Research May 2023, 43 (5) 2085-2090; DOI: https://doi.org/10.21873/anticanres.16369
You have access
Lack of Association of Proteinuria and Clinical Outcome in Patients Treated with Bevacizumab for Metastatic Colorectal Cancer
SATORU IWASA, TAKAKO EGUCHI NAKAJIMA, KENGO NAGASHIMA, YOSHITAKA HONMA, KEN KATO, TETSUYA HAMAGUCHI, YASUHIDE YAMADA and YASUHIRO SHIMADA

Anticancer Research January 2013, 33 (1) 309-316;

Main menu